Major depressive disorder and inflammatory markers in elderly patients with heart failure.

The authors evaluated levels of inflammatory markers in 34 chronic heart failure (CHF) out-patients age 65 years and over, with (N=18) and without (N=16) major depressive disorder (MDD), and healthy-control subjects (N=13). Patients with CHF had left-ventricular ejection fractions <0.40 and were in the New York Heart Association functional class II or III. The authors used the SCID DSM-IV to diagnosis MDD. High-sensitivity C-reactive protein levels were significantly higher in patients with CHF and MDD as compared with healthy-control subjects. No differences regarding tumor necrosis factor(alpha) or interleukin(6) were found among the three groups.

[1]  H. Crijns,et al.  Erratum to “Inflammatory markers in depressed post-myocardial infarction patients”[J Psychiatric Res 39 (2005) 137–144] , 2005 .

[2]  X. Jouven,et al.  Contributions of Depressive Mood and Circulating Inflammatory Markers to Coronary Heart Disease in Healthy European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) , 2005, Circulation.

[3]  E. Caine,et al.  Inflammatory markers, depression, and cardiac disease. , 2005, The American journal of psychiatry.

[4]  H. Crijns,et al.  Inflammatory markers in depressed post-myocardial infarction patients. , 2005, Journal of psychiatric research.

[5]  John P H Wilding,et al.  Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure , 2004, Heart.

[6]  Stamatis Adamopoulos,et al.  Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. , 2004, The American journal of cardiology.

[7]  Jaw-WenChen,et al.  Carvedilol Inhibits Tumor Necrosis Factor-α–Induced Endothelial Transcription Factor Activation, Adhesion Molecule Expression, and Adhesiveness to Human Mononuclear Cells , 2004 .

[8]  Shing‐Jong Lin,et al.  Carvedilol Inhibits Tumor Necrosis Factor-&agr;–Induced Endothelial Transcription Factor Activation, Adhesion Molecule Expression, and Adhesiveness to Human Mononuclear Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[9]  A. Struthers,et al.  Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study , 2004, Heart.

[10]  P. O'Malley,et al.  Relationship Between Depression and C-Reactive Protein in a Screening Population , 2004, Psychosomatic medicine.

[11]  T. Erlinger,et al.  Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. , 2004, Archives of internal medicine.

[12]  W. Yin,et al.  Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. , 2004, American heart journal.

[13]  M. Irwin,et al.  The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. , 2004, The American journal of psychiatry.

[14]  Harlan M Krumholz,et al.  Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. , 2003, Journal of the American College of Cardiology.

[15]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[16]  J. Denollet,et al.  Cytokines and immune activation in systolic heart failure: the role of Type D personality , 2003, Brain, Behavior, and Immunity.

[17]  Viola Vaccarino,et al.  Association Between Depression and Elevated C-Reactive Protein , 2003, Psychosomatic medicine.

[18]  A. Steptoe,et al.  Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women , 2003, Psychological Medicine.

[19]  R. Carney,et al.  Prevalence of Depression in Hospitalized Patients With Congestive Heart Failure , 2003, Psychosomatic medicine.

[20]  A. Hofman,et al.  Inflammatory proteins and depression in the elderly. , 2003, Epidemiology.

[21]  R. Carney,et al.  Clinical depression and inflammatory risk markers for coronary heart disease. , 2002, The American journal of cardiology.

[22]  Stephan Arndt,et al.  Prevalence and Correlates of Depressive Symptoms in a Community Sample of People Suffering from Heart Failure , 2002, Journal of the American Geriatrics Society.

[23]  M. Henein,et al.  Clinical depression is common and significantly associated with reduced survival in patients with non‐ischaemic heart failure , 2002, European journal of heart failure.

[24]  S. Hosoda,et al.  Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy. , 2002, Journal of cardiology.

[25]  S. Verma,et al.  Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein , 2002, Circulation.

[26]  L. Fried,et al.  Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. , 2002, The American journal of cardiology.

[27]  C M O'Connor,et al.  Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. , 2001, Archives of internal medicine.

[28]  H. Krumholz,et al.  Depressive symptoms and risk of functional decline and death in patients with heart failure. , 2001, Journal of the American College of Cardiology.

[29]  S. Grundy,et al.  Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels , 2001, Circulation.

[30]  R. Dantzer.  Cytokine‐Induced Sickness Behavior: Mechanisms and Implications , 2001, Annals of the New York Academy of Sciences.

[31]  W. Koenig.  C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile? , 2001, Italian heart journal : official journal of the Italian Federation of Cardiology.

[32]  M. Fisher,et al.  Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. , 2000, Journal of cardiac failure.

[33]  James T. Willerson,et al.  Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells , 2000, Circulation.

[34]  M. D. de Baets,et al.  Inflammation, depressive symptomtology, and coronary artery disease. , 2000, Psychosomatic medicine.

[35]  W. Kop,et al.  Association between depression and mortality in older adults: the Cardiovascular Health Study. , 2000, Archives of internal medicine.

[36]  K. Kataoka,et al.  Serial circulating concentrations of c‐reactive protein, interleukin (il)‐4, and il‐6 in patients with acute left heart decompensation , 1999, Clinical cardiology.

[37]  R. Nagai,et al.  C-Reactive Protein in Dilated Cardiomyopathy , 1999, Cardiology.

[38]  E. Havranek,et al.  Prevalence of depression in congestive heart failure. , 1999, The American journal of cardiology.

[39]  P. Ridker,et al.  Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.

[40]  W. Colucci,et al.  New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress , 1998, The Lancet.

[41]  N. Takahashi,et al.  Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. , 1998, The Journal of clinical investigation.

[42]  D. Fukai,et al.  Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[43]  B. Leonard,et al.  Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.

[44]  H. Koenig,et al.  Depression in hospitalized older patients with congestive heart failure. , 1998, General hospital psychiatry.

[45]  M. Berk,et al.  Acute phase proteins in major depression. , 1997, Journal of psychosomatic research.

[46]  G. MacGowan,et al.  Circulating interleukin-6 in severe heart failure. , 1997, The American journal of cardiology.

[47]  S. Thompson,et al.  Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.

[48]  D. Zechner,et al.  Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. , 1996, The Journal of clinical investigation.

[49]  E. Bosmans,et al.  Indicators of immune activation in major depression , 1996, Psychiatry Research.

[50]  T. LeJemtel,et al.  Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. , 1996, Journal of the American College of Cardiology.

[51]  H. Oral,et al.  Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). , 1996, Journal of the American College of Cardiology.

[52]  B. Davis,et al.  Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). , 1996, Archives of internal medicine.

[53]  J. Hare,et al.  Role of nitric oxide in the regulation of myocardial function. , 1995, Progress in cardiovascular diseases.

[54]  H. Meltzer,et al.  Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. , 1995, Journal of affective disorders.

[55]  N. Takahashi,et al.  Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. , 1995, The Journal of clinical investigation.

[56]  P. Cannon,et al.  The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. , 1995, The Journal of clinical investigation.

[57]  H. Meltzer,et al.  Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression , 1993, Psychiatry Research.

[58]  M. Yoshizumi,et al.  Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. , 1993, Circulation research.

[59]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[60]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[61]  S. Cobbe,et al.  Study of serum C-reactive protein concentration in cardiac failure. , 1990, British heart journal.

[62]  A. Stewart,et al.  The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.

[63]  M. Neaverson,et al.  Sudden unexpected death. , 1967, The Medical journal of Australia.